← Evidence map

ReviewNature reviews. Clinical oncology2019

CRISPR-Cas: a tool for cancer research and therapeutics.

Hao Yin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

77 papers cite itlatest 60 shown

2019
…
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30664678